Gain Therapeutics Income Statement (2020-2025) | GANX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.01M0.01M0.01M0.01M0.01M0.09M0.03M0.04M0.05M0.10M0.06M
Operating items
Research & Development 0.42M0.44M0.43M0.98M1.42M1.79M2.48M1.47M1.56M2.58M1.96M2.27M2.79M3.99M2.37M2.37M2.51M4.44M2.62M1.22M2.26M2.76M2.85M
Selling, General & Administrative 0.10M0.10M0.40M0.65M1.05M1.81M2.19M1.78M1.78M2.69M2.79M2.29M2.49M3.74M2.52M2.03M1.87M3.75M1.84M2.11M2.11M2.33M1.94M
Operating Expenses 0.52M0.54M0.83M1.62M2.47M3.60M4.66M3.25M3.33M5.27M4.75M4.56M5.28M7.73M4.89M4.41M4.38M8.18M4.46M3.33M4.37M5.09M4.79M
Operating Income -0.51M-0.53M-0.82M-1.62M-2.47M-3.51M-4.64M-3.21M-3.29M-5.18M-4.75M-4.56M-5.23M-7.73M-4.89M-4.41M-4.38M-8.18M-4.46M-3.33M-4.37M-5.09M-4.79M
EBIT -0.51M-0.53M-0.82M-1.62M-2.47M-3.51M-4.64M-3.21M-3.29M-5.18M-4.75M-4.56M-5.23M-7.73M-4.89M-4.41M-4.38M-8.18M-4.46M-3.33M-4.37M-5.09M-4.79M
Non-operating items
Interest & Investment Income 0.12M0.08M0.11M0.05M0.04M0.04M0.08M
Other Non Operating Income -0.07M-0.00M0.03M-0.05M0.02M-0.04M-0.03M-0.02M0.02M0.04M0.04M-0.20M-0.04M-0.06M0.08M-0.41M0.27M-0.04M-0.12M0.02M-0.10M-0.62M-0.03M
Net income details
EBT -0.58M-0.54M-0.79M-1.66M-2.45M-3.55M-4.66M-3.23M-3.27M-5.08M-4.55M-4.60M-5.12M-7.66M-4.70M-5.00M-3.99M-8.14M-4.47M-5.78M-4.43M-5.67M-4.74M
Tax Provisions 0.00M0.00M885.00-0.00M0.00M0.00M0.01M-0.01M0.00M0.01M0.00M0.08M0.02M0.03M0.02M0.01M0.02M0.00M0.01M0.50M0.10M0.14M0.55M
Profit After Tax -0.58M-0.54M-0.79M-1.66M-2.45M-3.56M-4.66M-3.22M-3.27M-5.09M-4.56M-4.67M-5.14M-7.69M-4.72M-4.72M-4.01M-8.14M-4.49M-3.77M-4.53M-5.81M-5.28M
Income from Continuing Operations -0.58M-0.54M-0.79M-1.66M-2.45M-3.56M-4.66M-3.22M-3.27M-5.09M-4.56M-4.67M-5.14M-7.69M-4.72M-5.01M-4.01M-8.14M-4.49M-6.28M-4.53M-5.81M-5.28M
Consolidated Net Income -0.58M-0.54M-0.79M-1.66M-2.45M-3.56M-4.66M-3.22M-3.27M-5.09M-4.56M-4.67M-5.14M-7.69M-4.72M-5.01M-4.01M-8.14M-4.49M-6.28M-4.53M-5.81M-5.28M
Income towards Parent Company -0.58M-0.54M-0.79M-1.66M-2.45M-3.56M-4.66M-3.22M-3.27M-5.09M-4.56M-4.67M-5.14M-7.69M-4.72M-5.01M-4.01M-8.14M-4.49M-6.28M-4.53M-5.81M-5.28M
Net Income towards Common Stockholders -0.58M-0.54M-0.79M-1.66M-2.45M-3.56M-4.66M-3.22M-3.27M-5.09M-4.56M-4.67M-5.14M-7.69M-4.72M-5.01M-4.01M-8.14M-4.49M-6.28M-4.53M-5.81M-5.28M
Additional items
EPS (Basic) -0.29-0.27-0.25-0.53-0.50-0.30-0.39-0.26-0.28-0.43-0.38-0.39-0.43-0.62-0.37-0.29-0.22-0.42-0.17-0.27-0.16-0.19-0.15
EPS (Weighted Average and Diluted) -0.27-0.25-0.53-0.50-0.30-0.39-0.26-0.28-0.43-0.38-0.39-0.43-0.62-0.37-0.29-0.22-0.42-0.17-0.27-0.16-0.19-0.15
Shares Outstanding (Weighted Average) 1.98M1.98M3.20M2.68M4.87M11.88M11.88M10.17M11.88M11.88M11.88M11.88M11.94M12.39M12.70M13.01M17.98M19.22M26.53M22.88M28.69M30.34M35.00M
Shares Outstanding (Diluted Average) 1.98M3.20M2.68M4.87M11.88M11.88M10.17M11.88M11.88M11.88M11.88M11.94M12.39M12.70M13.01M17.98M19.22M26.53M22.88M28.69M30.34M35.00M
EBITDA -0.51M-0.53M-0.82M-1.62M-2.47M-3.51M-4.64M-3.21M-3.29M-5.18M-4.75M-4.56M-5.23M-7.73M-4.89M-4.41M-4.38M-8.18M-4.46M-3.33M-4.37M-5.09M-4.79M
Shares Outstanding 1.98M1.98M3.54M3.54M11.88M11.88M11.88M11.88M11.88M11.88M11.88M11.88M12.09M12.63M12.78M16.21M18.04M25.17M25.96M27.13M28.75M30.77M35.98M
Tax Rate -0.23-0.84-0.110.08-0.14-0.10-0.110.26-0.05-0.18-0.09-1.70-0.33-0.35-0.46-0.29-0.50-0.01-0.25-8.74-2.27-2.49-11.60